134 related articles for article (PubMed ID: 21337401)
1. Development of nanoparticle-based magnetic resonance colonography.
Sun J; Zheng W; Zhang H; Wu T; Yuan H; Yang X; Zhang S
Magn Reson Med; 2011 Mar; 65(3):673-9. PubMed ID: 21337401
[TBL] [Abstract][Full Text] [Related]
2. Magnetic resonance colonography with intestine-absorbable nanoparticle contrast agents in evaluation of colorectal inflammation.
Dong X; Luo J; Lan P; Guo X; Zhao X; Wang X; Zhou F; Wang Q; Yuan H; Sun J
Eur Radiol; 2021 Jul; 31(7):4615-4624. PubMed ID: 33409796
[TBL] [Abstract][Full Text] [Related]
3. Gadolinium-Loaded Solid Lipid Nanoparticles as a Tumor-Absorbable Contrast Agent for Early Diagnosis of Colorectal Tumors Using Magnetic Resonance Colonography.
Sun J; Zhang S; Jiang S; Bai W; Liu F; Yuan H; Ji J; Luo J; Han G; Chen L; Jin Y; Hu P; Yu L; Yang X
J Biomed Nanotechnol; 2016 Sep; 12(9):1709-23. PubMed ID: 29345451
[TBL] [Abstract][Full Text] [Related]
4. Gadolinium-Loaded Solid Lipid Nanoparticles for Colorectal Tumor in MR Colonography.
Wang H; Ding W; Peng L; Fan H; Yan C; Xu S; Sun J; Zhu X
J Biomed Nanotechnol; 2020 May; 16(5):594-602. PubMed ID: 32919480
[TBL] [Abstract][Full Text] [Related]
5. Development of a Novel MR Colonography via Iron-Based Solid Lipid Nanoparticles.
Wang H; Wang S; Zhu X; Ding W; Shen T; Fan H; Zhang Y; Peng L; Yuan H; Liu X; Ling J; Sun J
Int J Nanomedicine; 2022; 17():821-836. PubMed ID: 35228799
[TBL] [Abstract][Full Text] [Related]
6. Bimodal visualization of colorectal uptake of nanoparticles in dimethylhydrazine-treated mice.
Wu T; Zheng WL; Zhang SZ; Sun JH; Yuan H
World J Gastroenterol; 2011 Aug; 17(31):3614-22. PubMed ID: 21987608
[TBL] [Abstract][Full Text] [Related]
7. Intercellular imaging by a polyarginine derived cell penetrating peptide labeled magnetic resonance contrast agent, diethylenetriamine pentaacetic acid gadolinium.
Guo YM; Liu M; Yang JL; Guo XJ; Wang SC; Duan XY; Wang P
Chin Med J (Engl); 2007 Jan; 120(1):50-5. PubMed ID: 17254488
[TBL] [Abstract][Full Text] [Related]
8. Size-stable solid lipid nanoparticles loaded with Gd-DOTA for magnetic resonance imaging.
Andreozzi E; Wang P; Valenzuela A; Tu C; Gorin F; Dhenain M; Louie A
Bioconjug Chem; 2013 Sep; 24(9):1455-67. PubMed ID: 24004269
[TBL] [Abstract][Full Text] [Related]
9. [Application of anoptomagnetic probe Gd-DO3A-EA-FITC in imaging and analyzing the brain interstitial space].
Li YQ; Sheng Y; Liang L; Zhao Y; Li HY; Bai N; Wang T; Yuan L; Han HB
Beijing Da Xue Xue Bao Yi Xue Ban; 2018 Apr; 50(2):221-225. PubMed ID: 29643518
[TBL] [Abstract][Full Text] [Related]
10. New dual mode gadolinium nanoparticle contrast agent for magnetic resonance imaging.
Ghaghada KB; Ravoori M; Sabapathy D; Bankson J; Kundra V; Annapragada A
PLoS One; 2009 Oct; 4(10):e7628. PubMed ID: 19893616
[TBL] [Abstract][Full Text] [Related]
11. Development of Bifunctional Gadolinium-Labeled Superparamagnetic Nanoparticles (Gd-MnMEIO) for In Vivo MR Imaging of the Liver in an Animal Model.
Kuo YT; Chen CY; Liu GC; Wang YM
PLoS One; 2016; 11(2):e0148695. PubMed ID: 26886558
[TBL] [Abstract][Full Text] [Related]
12. Gadolinium-chitosan nanoparticles as a novel contrast agent for potential use in clinical bowel-targeted MRI: a feasibility study in healthy rats.
Cheng JJ; Zhu J; Liu XS; He DN; Xu JR; Wu LM; Zhou J; Feng Q
Acta Radiol; 2012 Oct; 53(8):900-7. PubMed ID: 22919051
[TBL] [Abstract][Full Text] [Related]
13. Gadolinium-conjugated PLA-PEG nanoparticles as liver targeted molecular MRI contrast agent.
Chen Z; Yu D; Liu C; Yang X; Zhang N; Ma C; Song J; Lu Z
J Drug Target; 2011 Sep; 19(8):657-65. PubMed ID: 21091273
[TBL] [Abstract][Full Text] [Related]
14. Development of a macromolecular dual-modality MR-optical imaging for sentinel lymph node mapping.
Melancon MP; Wang Y; Wen X; Bankson JA; Stephens LC; Jasser S; Gelovani JG; Myers JN; Li C
Invest Radiol; 2007 Aug; 42(8):569-78. PubMed ID: 17620940
[TBL] [Abstract][Full Text] [Related]
15. Gd (III) complex conjugate of low-molecular-weight chitosan as a contrast agent for magnetic resonance/fluorescence dual-modal imaging.
Huang Y; Boamah PO; Gong J; Zhang Q; Hua M; Ye Y
Carbohydr Polym; 2016 Jun; 143():288-95. PubMed ID: 27083371
[TBL] [Abstract][Full Text] [Related]
16. Upconverting rare-earth nanoparticles with a paramagnetic lanthanide complex shell for upconversion fluorescent and magnetic resonance dual-modality imaging.
Wang Y; Ji L; Zhang B; Yin P; Qiu Y; Song D; Zhou J; Li Q
Nanotechnology; 2013 May; 24(17):175101. PubMed ID: 23558298
[TBL] [Abstract][Full Text] [Related]
17. Detection of hepatocellular carcinoma in transgenic mice by Gd-DTPA- and rhodamine 123-conjugated human serum albumin nanoparticles in T1 magnetic resonance imaging.
Watcharin W; Schmithals C; Pleli T; Köberle V; Korkusuz H; Hübner F; Waidmann O; Zeuzem S; Korf HW; Terfort A; Gelperina S; Vogl TJ; Kreuter J; Piiper A
J Control Release; 2015 Feb; 199():63-71. PubMed ID: 25499552
[TBL] [Abstract][Full Text] [Related]
18. Visual targeted therapy of hepatic cancer using homing peptide modified calcium phosphate nanoparticles loading doxorubicin guided by T1 weighted MRI.
Zhang NN; Yu RS; Xu M; Cheng XY; Chen CM; Xu XL; Lu CY; Lu KJ; Chen MJ; Zhu ML; Weng QY; Hui JG; Zhang Q; Du YZ; Ji JS
Nanomedicine; 2018 Oct; 14(7):2167-2178. PubMed ID: 30017962
[TBL] [Abstract][Full Text] [Related]
19. T1-Weighted MR imaging of liver tumor by gadolinium-encapsulated glycol chitosan nanoparticles without non-specific toxicity in normal tissues.
Na JH; Lee S; Koo H; Han H; Lee KE; Han SJ; Choi SH; Kim H; Lee S; Kwon IC; Choi K; Kim K
Nanoscale; 2016 May; 8(18):9736-45. PubMed ID: 27113247
[TBL] [Abstract][Full Text] [Related]
20. A small MRI contrast agent library of gadolinium(III)-encapsulated supramolecular nanoparticles for improved relaxivity and sensitivity.
Chen KJ; Wolahan SM; Wang H; Hsu CH; Chang HW; Durazo A; Hwang LP; Garcia MA; Jiang ZK; Wu L; Lin YY; Tseng HR
Biomaterials; 2011 Mar; 32(8):2160-5. PubMed ID: 21167594
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
